The following table shows the computation of basic and diluted earnings per share for the three-month periods ended April 5, 2026 and March 30, 2025 (in thousands, except per share amounts):


	Three-months Ended
	April 5, 2026	March 30, 2025
Net income	51,704	23,603
Basic weighted-average common and common-equivalent shares outstanding	166,514	169,265
Effect of dilutive stock-based awards	1,872	1,126
Diluted weighted-average common and common-equivalent shares outstanding	168,386	170,391
Earnings per share
Basic	0.31	0.14
Diluted	0.31	0.14

The computation of diluted weighted-average common shares outstanding excludes the following weighted average anti-dilutive stock-based awards outstanding for the three-month periods ended April 5, 2026 and March 30, 2025 (in thousands):


	Three-months Ended
	April 5, 2026	March 30, 2025
Stock options	5,945	9,765
Restricted stock units	376	—
Performance restricted stock units	41	—
Total weighted average anti-dilutive stock-based awards outstanding	6,362	9,765